Opendata, web and dolomites

Embryospin

Increasing IVF success rate through the first magnetic resonance system for embryonic quantitative analysis at the cell scale

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Embryospin project word cloud

Explore the words cloud of the Embryospin project. It provides you a very rough idea of what is the project "Embryospin" about.

technique    decades    strategy    ivf    morphological    screening    despite    engineering    device    resonance    commercialization    fulfil    national    poised    disposable    technologies    performances    magnetic    33    healthcare    nuclear    fold    france    pricing    prospective    optical    provides    filed    investment    refine    beginning    biopsy    tissue    germany    business    pad    pave    micronmr    infertile    embryos    market    patent    commercialize    subsidize    bench    desire    validate    microscope    couples    customers    attract    opportunity    savings    microns    qualitative    starting    hour    annaida    radically    validation    chemical    plan    sensor    invasive    launch    performed    microscopic    nmr    belgium    techniques    fertilization    coupled    turn    rates    screen    scaling    purely    frustratingly    preparation    surprisingly    embryo    improvement    insights    viability    performs    today    labels    embryospin    2021    laboratories    suitable    rate    family    costly    vitro   

Project "Embryospin" data sheet

The following table provides information about the project.

Coordinator
ANNAIDA TECHNOLOGIES SARL 

Organization address
address: AVENUE LOUIS-RUCHONNET 26
city: LAUSANNE
postcode: 1003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website https://www.linkedin.com/company/annaida-technologies/about/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ANNAIDA TECHNOLOGIES SARL CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

Today 1 out of 6 couples turn to the In Vitro Fertilization (IVF) technique to fulfil their desire of starting a family. Despite decades of research and high costs, the success rate of IVF remains frustratingly low (33%). A key factor in determining the IVF success is the embryo screening to determine viability. Surprisingly enough, embryo selection is currently performed through optical analysis with a microscope, that is a purely morphological, qualitative assessment that provides no reliable insights on embryo viability. Other available techniques are costly and invasive, since require the use of chemical labels or even a tissue biopsy. Annaida Technologies has developed Embryospin, a patent-filed device that performs microscopic Nuclear Magnetic Resonance (microNMR) at a scale of 100 microns, a 10-fold improvement over existing technologies. Annaida will develop and commercialize an NMR bench-top device, coupled with a disposable microNMR sensor able to screen up to 10 embryos in less than an hour. The technology is poised to radically increase the IVF laboratories’ success rates, thus ensuring significant savings to infertile couples and also to National Healthcare Systems that subsidize IVF costs, like France, Belgium and Germany. The Phase 1 project will be a launch pad for the future commercialization of the system, enabling to validate the Embryospin performances and the market opportunity, determine the most suitable pricing strategy, and refine the business plan to attract the future investment needed for scaling up the production. The following step will be to proceed with system engineering and preparation to the in-field validation (Phase 2) together with large prospective customers, which will pave the way to the beginning of the commercialization phase in 2021.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYOSPIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYOSPIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Manuback (2019)

MANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods

Read More  

TalentVision (2019)

INSIGHTS FOR TALENT ASSESSMENT USING COMPUTER VISION TECHNIQUES FROM NEURO PSYCHOLOGY

Read More  

Project Tracworx (2019)

Tracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.

Read More